Insights into Oncology

Latest updates and research & Real Patient Journey

Complete Response in Lower Tracheal Malignancy with CCRT
May 05, 2026

Complete Response in Lower Tracheal Malignancy with CCRT

Clinical Success Story: Complete Response in Lower Tracheal Malignancy with CCRT Managing rare airway malignancies often demands a balance of urgency, precision, and multidisciplinary coordination. I would like to share a recent real-world case that highlights the impact of a well-executed multimodal approach. A 61-year-old female presented with severe airway-compromising symptoms—progressive breathlessness, persistent cough, and hemoptysis. Evaluation confirmed invasive squamous cell carcinoma of the lower trachea (Grade II). Baseline disease burden: Tumor volume: 12.4 cc Symptomatic airway compromise Management strategy: Endoscopic debulking with CRYO + APC for immediate airway relief Definitive radiotherapy (3DCRT): 54 Gy in 27 fractions Concurrent weekly Cisplatin-based chemotherapy (CCRT) Response dynamics: Interim imaging showed 87% tumor reduction (down to 1.6 cc) with nodal clearance Final follow-up imaging (May 2026) demonstrated: Complete radiological response No residual tracheal mass No nodal or distant disease This outcome reinforces several key clinical insights: Even in rare central airway tumors, a structured multimodal strategy can achieve curative outcomes CCRT remains a powerful organ-preserving approach in patients not suitable for surgery Early airway stabilization + timely systemic sensitization is critical Real-world data continues to validate outcomes comparable to controlled settings As we continue to build real-world oncology evidence from Bangladesh, such cases highlight the importance of precision planning, multidisciplinary care, and context-adapted treatment strategies. Would be interested to hear thoughts from colleagues managing central airway malignancies—especially regarding optimal RT techniques (3DCRT vs IMRT/VMAT) and systemic intensification strategies. #Oncology #RadiationOncology #CCRT #AirwayTumors #CarcinomaTrachea #RealWorldEvidence #PrecisionOncology #CancerCare #Bangladesh #MultidisciplinaryCare #ClinicalSuccess #BSHL #BSH

D
Dr. Md. Arifur Rahman
Read Full Article
5 Year of Journey of denovo Metastatic CA Rectum
Apr 20, 2026

5 Year of Journey of denovo Metastatic CA Rectum

Carcinoma of Rectum with abdominal lymphadenopathy with multiple Liver SOL (Aug 21) > Post Palliative chemotherapy with FOLFOX-B > Capecitabine- Bevacizumab > Underwent surgery > Post 2nd line Palliative ChT with FOLFIRI B> Post FOLFIRINOX-B> On Oral Trifluridine & Tipiracil (D1-5, D8-12) + Regora 80mg, q4w > PD> Post Pal ChT with Irinotecan + Beva> On Oxaliplatin 150mg D1+ Beva 300mg D1 + Trifluridine-tipiracil 45mg> PD (July 25)> Post SBRT to Liver & On S1> PD on liver mass (Nov 2025)> With High Blirubin (Jan 26)> PD> Post ERCP with Stenting (20 March 26)> Expired April 2026

D
Dr. Md. Arifur Rahman
Read Full Article
Head & Neck Cancer Awareness Month | April
Apr 14, 2026

Head & Neck Cancer Awareness Month | April

Head and neck cancers represent a significant portion of the cancer burden in South Asia, including Bangladesh. One survey estimated that over one-third (35%) of all cancers in Bangladesh arise in the head-neck region, with carcinoma of the larynx identified as the most common head-neck malignancy

D
Dr. Md. Arifur Rahman
Read Full Article
Colorectal Cancer Awareness Month
Mar 30, 2026

Colorectal Cancer Awareness Month

Rectal Cancer in Bangladesh: Insights from BSH (5-Year Institutional Review) Colorectal cancer is an emerging health challenge worldwide. According to GLOBOCAN 2022, it is the 8th most common cancer globally and the 10th leading cause of cancer-related death.

D
Dr. Md. Arifur Rahman
Read Full Article